CA
NZ
UK
AU
IND
US
Price decline follows earnings release · Market reaction contrasts with financial results · Next catalyst: Full-year 2026 outlook update
Arcutis Biotherapeutics has expanded its board of directors with the addition of Christopher Peetz, a key executive from Mirum Pharmaceuticals. This appointment aligns with the company’s strategic focus on commercializing its ZORYVE franchise and advancing its pipeline in immuno-dermatology. As Arcutis continues to establish …
Cosmos Health has established a new class of preferred stock that contributes one hundred million votes, enabling board actions even when shareholder participation falls short of the quorum demanded by Nevada law. This step follows a recent annual meeting where only approximately 47% of …
Gyre Therapeutics (NASDAQ: GYRE) announced the appointment of three new directors effective Aug. 1, 2026, bringing fresh scientific and operational expertise to its board. The three appointees, Chief Scientific Officer Dr.
The sale, executed under a prearranged trading plan, comes as Precigen’s orphan drug status for Papzimeos grants market exclusivity through August 2032, a catalyst that has propelled the stock to multi-year highs. While insider sales under 10b5-1 plans are often routine, the timing, amid …
Bio-Path Holdings has raised capital through two unregistered share sales under its Regulation A offering, leaving additional funding capacity as it scrambles to fund a strategic pivot that now includes crypto investments and AI-driven drug trials. The company issued 466,100 common shares on April …
Entera Bio Ltd. has cleared a key corporate milestone, obtaining shareholder consent to more than double its authorized ordinary share count. The vote, conducted at the 2026 annual meeting, also endorsed a one‑time augmentation of its equity incentive pool and introduced three additional directors …
Getinge AB (OTC: GNGBY) posted earnings per share of $1.80 for the quarter ended March 31, surpassing the $1.70 consensus. The result arrived as the stock lingered at $20.05, reflecting a 9.3% decline since the start of the year while remaining unchanged over the …
Flash Sports & Media Holdings has replaced three directors, including its chairman, as the cricket‑focused media company seeks to stabilize operations amid a substantial stock decline this year. The reshuffle, effective recently, removes Bradley Nattrass from the chair but retains him in an executive …
Markets, as the former president reignited disputed claims about the 2020 election while pushing for a contentious legislative overhaul. The primetime speech, delivered ahead of the midterm elections, targeted Republican lawmakers with a call to pass the SAVE America Act, a bill analysts describe …
Please wait processing your request...